Dispensing with the Truth: The Victims, the Drug Companies, and the Dramatic Story Behind the Battle Over Fen-Phen
Semi-finalist for the Robert F. Kennedy Memorial Book Award
In 1996, a terrible epidemic began killing young American women. Some died quickly, literally dropping in their steps. Others took more time, from a few months to a few years. Those who weren't killed suffered damage to their lungs and hearts, much of it permanent and reparable only with major surgery. Doctors suspected what the killer was. So did the Food and Drug Administration. The culprits were the two most popular diet drugs in the United States, Pondimin, one-half of the popular drug combination Fen-Phen, and Redux, a stronger version of Pondimin. They were also two of the most profitable drugs on the market, and both were produced and sold by a powerful pharmaceutical company, Wyeth-Ayerst, a division of American Home Products.
Dispensing the Truth is the gripping storry of what the drug really knew about its drugs, the ways it kept this information from the public, doctors, and FDA, and the massive legal battles that ensued as victims and their attorneys searched for the truth behind the debacle.
It tells the story of a healthy young woman, Mary Linnen, who took the drugs for only twenty-three days to lose weight before her wedding, and then died in the arms of her fiance a few months later. Hers was the first wrongful-death suit filed amd would become the most important single suit the company would ever face.
Alicia Mundy provides a shocking and thoroughly riveting narrative. It is a stark look at the consequences of greed and a cautionary tale for the future.
What people are saying - Write a review
LibraryThing ReviewUser Review - MaryRW - LibraryThing
This book will make you furious, and it will make you think twice (or three or four times) about the drugs you take, especially ones that have only recently been approved by the FDA. Alicia Mundy ... Read full review
Other editions - View all
Dispensing with the Truth: The Victims, the Drug Companies, and the Dramatic ...
No preview available - 2002
Abby Landzberg Abenhaim Acri added AHP's lawyers Alex MacDonald Alex's American Home Products Aminorex approved Arnold & Porter asked attorneys began Bilstad Black Box Black Box warning Blackburn Boston Brassard called cardiologist clients clinical Connelly court courtroom Crary defense deposition diet drugs doctors documents drug companies e-mails Essner experts Fargo FDA officials FDA's Fen-Phen fenfluramine Fishbein Fisons Flolan going Hoynes Interneuron IPPHS issue judge jurors jury Kip and Robert Kip's knew litigation looked Marc Deitch Mary Linnen Mary's Maureen Mayo meeting memo Mike Mike Williams million months Myers obesity patients pharmaceutical Phentermine plaintiffs Pondimin Pondimin and Redux Pondimin label problems reports Restaino Rich Rotman safety Servier settlement side effects Sobel Steve talk tell Texans Texas tion told took trial trying valve disease valvulopathy wanted Weiner Weintraub Weiss Wilson Wurtman Wyeth Wyeth-Ayerst
Page 389 - MJ, et al: Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months.
Guiding Icarus: Merging Bioethics with Corporate Interests
Rahul K. Dhanda
Limited preview - 2003
All Book Search results »
Big Fat Lies: The Truth about Your Weight and Your Health
Glenn A. Gaesser
No preview available - 2002